Definitive Healthcare Corp. (DH)
| Market Cap | 194.65M -31.2% |
| Revenue (ttm) | 227.31M -6.2% |
| Net Income | -157.25M |
| EPS | -1.50 |
| Shares Out | 145.26M |
| PE Ratio | n/a |
| Forward PE | 7.47 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 431,895 |
| Open | 1.300 |
| Previous Close | 1.310 |
| Day's Range | 1.290 - 1.400 |
| 52-Week Range | 0.610 - 3.000 |
| Beta | 1.36 |
| Analysts | Hold |
| Price Target | 1.63 (+21.27%) |
| Earnings Date | Nov 5, 2026 |
About DH
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician... [Read more]
Financial Performance
In 2025, Definitive Healthcare's revenue was $241.52 million, a decrease of -4.24% compared to the previous year's $252.20 million. Losses were -$138.93 million, -66.37% less than in 2024.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for DH stock is "Hold." The 12-month stock price target is $1.63, which is an increase of 21.27% from the latest price.
News
Healthcare Leaders Turn Months-Long Analyses Into Minutes With AI-Powered Growth Intelligence Platform
Definitive Healthcare shares early-adopter findings for new AI-powered growth intelligence platform used to power critical healthcare decisions and commercial progress Definitive Healthcare shares ear...
Definitive Healthcare reports Q3 adjusted EPS 6c, consensus 4c
Reports Q3 revenue $54.65M, consensus $54.58M. “Since joining Definitive, I’ve been focused on listening to our customers and our employees,” said Clay Ritchey, CEO of Definitive Healthcare (DH). “Wha...
Definitive Healthcare Reports Financial Results for Third Quarter 2026
FRAMINGHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, to...
Definitive Healthcare Earnings release: Q3 2026
Definitive Healthcare released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Definitive Healthcare Quarterly report: Q3 2026
Definitive Healthcare has published its Q3 2026 quarterly earnings report on November 5, 2026.
Definitive Healthcare appoints Rebecca Marani as CPO
Definitive Healthcare (DH) announced the expansion of its leadership team, adding Rebecca Marani as Chief Product Officer and Srinivas Attipalli as SVP, Head of AI and Data. Marani joined Definitive…
Definitive Healthcare announces executive appointments to bolster AI-powered initiatives across the company
Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer
Definitive Healthcare joins Network Advertising Initiative
Definitive Healthcare (DH) announced that it has joined the Network Advertising Initiative, NAI. “Membership in the NAI underscores Definitive Healthcare’s commitment to responsible data stewardship a...
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety Alongside other industry leaders, Definitive Healthcare demonstrates commi...
Definitive Healthcare moved to No Rating at BofA
BofA moved to No Rating on Definitive Health after the company announced its board received a nonbinding indication of interest from Advent International to acquire all of the outstanding shares…
Definitive Healthcare confirms going-private proposal from Advent International
The special committee of the board of directors of Definitive Healthcare (DH) announced that it has received a non-binding indication of interest from Advent International on behalf of certain of…
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry...
Definitive Healthcare CEO Kevin Coop departs, Clay Ritchey succeeds
Definitive Healthcare (DH) announced that its board of directors has appointed Clay Ritchey as the company’s next CEO and as a member of the board of directors, each effective September…
Definitive Healthcare Appoints Clay Ritchey as CEO
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced th...
Definitive Healthcare price target lowered to $1 from $3 at Deutsche Bank
Deutsche Bank analyst George Hill lowered the firm’s price target on Definitive Healthcare (DH) to $1 from $3 and keeps a Hold rating on the shares.
Definitive Healthcare price target lowered to $1.50 from $2.50 at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach lowered the firm’s price target on Definitive Healthcare (DH) to $1.50 from $2.50 and keeps an Equal Weight rating on the shares. The firm, which…
Definitive Healthcare Earnings Call Transcript: Q2 2026
Q2 2026 results met or exceeded guidance, with revenue down 9% year-over-year and strong profitability. Strategic investments in AI, data, and digital activation are driving customer retention and new wins, while the Turbo platform is expected to support future growth.
Definitive Healthcare Slides: Q2 2026
Definitive Healthcare has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 10, 2026.
Definitive Healthcare Earnings release: Q2 2026
Definitive Healthcare released its Q2 2026 earnings on August 10, 2026, summarizing the period's financial results.
Definitive Healthcare Quarterly report: Q2 2026
Definitive Healthcare has published its Q2 2026 quarterly earnings report on August 10, 2026.
Definitive Healthcare raises FY26 adjusted EPS view to 18c-20c from 16c-19c
Consensus 18c. Narrows FY26 revenue view to $220M from $220M-$226M, consensus $223.45M. Sees FY26 adjusted EBITDA view $57M-$59M.
Definitive Healthcare reports Q2 adjusted EPS 5c, consensus 4c
Reports Q2 revenue $55.2M, consensus $55.39M. “Definitive Healthcare (DH) delivered another quarter in line with or above our guidance ranges, reflecting continued discipline alongside targeted invest...
Definitive Healthcare sees Q3 adjusted EPS 4c-5c, consensus 4c
Sees Q3 revenue $54M-$55M, consensus $55.38M. Sees Q3 adjusted EBITDA $13.5M-$14.5M.
Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform
Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions Unifying claims, provider, consumer, and expert da...
Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced tha...